Mumps virus vaccine live
Trade name: MumpsVax
Vaccineapproved
Approved
Dec 28, 1967
Clinical trial activity
1 trials · 1 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 4, 2023 (NCT06208683)
Timeline
Indications
Approved for
Studied for
Mechanism of action
- Mumps virusImmunity, active
Mumps virus immunity, active
Approval history
- approvedDec 28, 1967
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109201 ↗
Also known as
- mumpsvax
- mumps virus vaccine, live attenuated
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06208683 | Phase 4 | Nov 4, 2023 | Sinovac Biotech Co., Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinovac Biotech Co., Ltd | For profit | 1 | 1 | 1 | 2023 |
1 organizations
Page 1 / 1